4 ms·

I'd be more sympathetic if they actually met the demand of their prescribed base. I have about a 40% success rate actually getting my rx filled and have to use

• mrweasel 2y ago
  My feeling is that Ozempic, and Wegovy, has been prescribed to too many, to fast. It was always clear that Novo Nordisk would not be able to the need of both diabetics, people who truly need to lose weight and those who just want to lose weight. The latter group should not be serviced at all at this point. Starting to push Wegovy was just a money grab, Novo must have known that it would disrupt their delivery of Ozempic.
  • consteval 2y ago
    The venn diagram of people who are diabetic and people who need to lose weight are almost a circle. If you're drastically overweight and not diabetic, that's because not enough time has passed. What people fail to realize is that obesity correlates highly with pretty much every bad thing you can develop. The faster you control obesity, the lower your risk will be. Virtually every organ in the body, from liver to kidneys to heart to lungs, is negatively impacted by obesity. I view it as people taking those drugs pre-emptively. They would require them, eventually.
• downrightmike 2y ago
  Compounding exists to fill the market gaps